Skip to content

Follow-up Groningen antithrombin study

Follow-up Groningen antithrombin study - vGRAS

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON56523
Enrollment
9
Registered
2024-02-21
Start date
2024-04-05
Completion date
Unknown
Last updated
2024-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

antithrombin deficiency blood clotting disorder

Interventions

None listed

Sponsors

Universitair Medisch Centrum Groningen
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: To be eligble for participation to this study, a participant needs to meet all inclusion criteria: - participated in the above-mentioned GRAS study as an index patient or as a first- or second-degree family member and met the following criteria: - Had laboratory findings indicating antithrombin deficiency - Had no genetic cause established - Gave consent for further research at that time; - Provided new consent for this study.

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

MeasureTime frame
Pathogenic or likely pathogenic mutation.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)